Picture EBD Group Biotech Showcase 2024 San Francisco 650x100px

Product › Details

Darzalex®

	Next higher product group	daratumumab
	Status	2016-04-04 sales existent
	Organisation	Janssen Biotech Inc. (JBI)
	Group	Johnson & Johnson (JnJ) (Group)
	Organisation 2	Genmab A/S (CSE: GEN, Nasdaq: GMAB)
	Group	Genmab (Group)

Record changed: 2023-07-10

Picture Berlin Partner Voices from HealthCapital Charpentier 650x200px

More documents for Darzalex®

[1] Genmab A/S. (12/13/19). "Press Release: CHMP Issues Positive Opinion Recommending Darzalex (Daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone in Frontline Multiple Myeloma". Copenhagen....
[2] Genmab A/S. (10/30/19). "Press Release: David Eatwell to Retire as Chief Financial Officer of Genmab". Copenhagen....
[3] Genmab A/S. (7/19/19). "Press Release: Genmab Announces Full Exercise of Underwriters’ Over-Allotment Option in Initial Public Offering". Copenhagen....
[4] Genmab A/S. (3/11/19). "Press Release: Genmab Announces Appointment of Marisol Peron as Head of Communications and Investor Relations". Copenhagen....
[5] Genmab A/S. (1/26/19). "Press Release: Genmab Announces that the Patents Asserted against Darzalex in the United States Have Been Declared Invalid by Summary Judgment". Copenhagen....
[6] Genmab A/S. (1/22/19). "Press Release: Genmab Announces 2018 Net Sales Figures for Darzalex (Daratumumab)". Copenhagen....
[7] Genmab A/S. (1/22/19). "Press Release: Genmab Announces Initiation of U.S. FDA Regulatory Submission for Label Expansion of Daratumumab in Combination with Lenalidomide and Dexamethasone in Front Line Multiple Myeloma". Copenhagen....
[8] Genmab A/S. (1/8/19). "Press Release: Genmab Achieves USD 75 Million Sales Milestone in Darzalex (daratumumab) Collaboration with Janssen". Copenhagen....
[9] Genmab A/S. (7/27/18). "Press Release: CHMP Issues Positive Opinion Recommending Darzalex (daratumumab) for Front Line Multiple Myeloma". Copenhagen....
[10] Genmab A/S. (1/23/18). "Press Release: Genmab Announces 2017 Net Sales Figures for Darzalex (daratumumab)". Copenhagen....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]